JUN_01
Asset
Cell reprogramming with siRNA.
- Stage
- Preclinical
- Modality
- Oligonucleotide
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Obesity
Preclinical, junevity.com, 10 Oct 2026
Type 2 diabetes
Preclinical, junevity.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors5
Every asset’s record: target, stage, trials and the evidence behind it.